Profile of Inflammatory Mediators in Gestational Diabetes Mellitus: Phenotype and Genotype

American Journal of Reproductive Immunology

Volumn 67, Issue 3, 2012, Pages 241-250

  Gueuvoghlanian Silva, Bárbara Yasmin ^a   Torloni, Maria Regina ^a   Mattar, Rosiane ^a   de Oliveira, Lilian Silveira ^a   Scomparini, Flávia Burim ^a   Nakamura, Mary Uchiyama ^a   Daher, Silvia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Cytokines; Genetic polymorphism; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; OBESITY; PHENOTYPE; PREGNANCY;

EID: 84856400954     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01090.x     Document Type: Article

References (58)

1. World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i-xii, 1-253.
2. World Health Organization: Obesity and Overweight. World Health Organization, 2011. [cited 2011 March]. Available from: (accessed 1 August 2011).
3. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R: Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373:1083-1096.
4. Sirimi N, Goulis DG: Obesity in pregnancy. Hormones (Athens) 2010; 9:299-306.
5. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O: Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009; 10:194-203.
6. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(Suppl 1):S62-S69.
7. Reece EA: The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010; 23:199-203.
8. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA: Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91:4137-4143.
9. Richardson AC, Carpenter MW: Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 2007; 34:213-224, vii.
10. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB: Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010; 53:757-767.
11. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B: Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85:3338-3342.
12. Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giugliano D: Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88:1055-1058.
13. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52:1779-1785.
14. Horosz E, Bomba-Opon DA, Szymanska M, Wielgos M: Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies. Diabetes Res Clin Pract 2011; 93:350-356.
15. Soheilykhah S, Mohammadi M, Mojibian M, Rahimi-Saghand S, Rashidi M, Hadinedoushan H, Afkhami-Ardekani M: Maternal serum adiponectin concentration in gestational diabetes. Gynecol Endocrinol 2009; 25:593-596.
16. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, Dong Z, Yoon BH, Hassan SS, Kusanovic JP: Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 2009; 37:637-650.
17. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B: Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010; 53:268-276.
18. Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, Rice GE: Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008; 45:157-165.
19. Choi YK, Kwak-Kim J: Cytokine gene polymorphisms in recurrent spontaneous abortions: a comprehensive review. Am J Reprod Immunol 2008; 60:91-110.
20. de Lima TH, Sass N, Mattar R, Moron AF, Torloni MR, Franchim CS, Daher S: Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens Res 2009; 32:565-569.
21. Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildirim G, Issever H, Eroglu H: Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. J Obstet Gynaecol Res 2010; 36:64-71.
22. Mattar R, de Souza E, Daher S: Preterm delivery and cytokine gene polymorphisms. J Reprod Med 2006; 51:317-320.
23. Montazeri S, Nalliah S, Radhakrishnan AK: Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas 2010; 147:94-102.
24. Chang Y, Niu XM, Qi XM, Zhang HY, Li NJ, Luo Y: [Study on the association between gestational diabetes mellitus and tumor necrosis factor-alpha gene polymorphism]. Zhonghua Fu Chan Ke Za Zhi 2005; 40:676-678.
25. Montazeri S, Nalliah S, Radhakrishnan AK: Association between polymorphisms in human tumor necrosis factor-alpha (-308) and -beta (252) genes and development of gestational diabetes mellitus. Diabetes Res Clin Pract 2010; 88:139-145.
26. Liang Z, Dong M, Cheng Q, Chen D: Gestational diabetes mellitus screening based on the gene chip technique. Diabetes Res Clin Pract 2010; 89:167-173.
27. Low CF, Mohd Tohit ER, Chong PP, Idris F: Adiponectin SNP45TG is associated with gestational diabetes mellitus. Arch Gynecol Obstet 2011; 283:1255-1260.
28. World Health Organization: Definition, Diagnosis and Classification of Mellitus and Its Complications. Geneva, World Health Organization, 1999.
29. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P: A fast method for high-quality genomic DNA extraction from whole human blood. BioTechniques 1991; 11:298-300, 302.
30. Chatterjee A, Rathore A, Sivarama P, Yamamoto N, Dhole TN: Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians. J Clin Immunol 2009; 29:71-77.
31. Gonzalez-Sanchez JL, Martinez-Calatrava MJ, Martinez-Larrad MT, Zabena C, Fernandez-Perez C, Laakso M, Serrano-Rios M: Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population. Clin Chem 2006; 52:97-103.
32. Jahromi MM, Millward BA, Demaine AG: A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20:885-888.
33. Li LL, Kang XL, Ran XJ, Wang Y, Wang CH, Huang L, Ren J, Luo X, Mao XM: Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol 2007; 34:1287-1290.
34. Dupont WD, Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11:116-128.
35. Morisset AS, Dube MC, Cote JA, Robitaille J, Weisnagel SJ, Tchernof A: Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011; 90:524-530.
36. Kuzmicki M, Telejko B, Zonenberg A, Szamatowicz J, Kretowski A, Nikolajuk A, Laudanski P, Gorska M: Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res 2008; 40:556-560.
37. Lapolla A, Dalfra MG, Sanzari M, Fedele D, Betterle C, Masin M, Zanchetta R, Faggian D, Masotti M, Nucera V, Plebani M: Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine 2005; 31:280-287.
38. Mahmoud F, Abul H, Omu A, Haines D: Lymphocyte sub-populations in gestational diabetes. Am J Reprod Immunol 2005; 53:21-29.
39. Nevers T, Kalkunte S, Sharma S: Uterine Regulatory T cells, IL-10 and hypertension. Am J Reprod Immunol 2011; 66(Suppl 1):88-92.
40. Schmidt MI, Duncan BB, Tavares M, Polanczyk CA, Pellanda L, Zimmer PM: Validity of self-reported weight - a study of urban Brazilian adults. Rev Saude Publica 1993; 27:271-276.
41. Chor D, Coutinho Eda S, Laurenti R: Reliability of self-reported weight and height among state bank employees. Rev Saude Publica 1999; 33:16-23.
42. Fonseca Mde J, Faerstein E, Chor D, Lopes CS: [Validity of self-reported weight and height and the body mass index within the "Pro-saude" study]. Rev Saude Publica 2004; 38:392-398.
43. Diez JJ, Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148:293-300.
44. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD: Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53:585-590.
45. Martin AM, Berger H, Nisenbaum R, Lausman AY, MacGarvie S, Crerar C, Ray JG: Abdominal visceral adiposity in the first trimester predicts glucose intolerance in later pregnancy. Diabetes Care 2009; 32:1308-1310.
46. Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, Vatish M, Randeva HS: Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006; 49:1292-1302.
47. Crawford LJ, Peake R, Price S, Morris TC, Irvine AE: Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis. J Leukoc Biol 2010; 88:807-811.
48. Daher S, Torloni MR, Gueuvoghlanian-Silva BY, Moron AF, Mattar R: Inflammatory mediators gene polymorphism and gestational diabetes: a review of the literature. J Reprod Immunol 2011; 90:111-116.
49. Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C: Interleukin 6-174G/C promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1626 pregnant women. Am J Reprod Immunol 2008; 59:347-351.
50. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG: Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003; 58:69-77.
51. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11:2607-2614.
52. Tischendorf JJ, Yagmur E, Scholten D, Vidacek D, Koch A, Winograd R, Gressner AM, Trautwein C, Wasmuth HE, Lammert F: The interleukin-6 (IL6)-174G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet 2007; 34:413-418.
53. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
54. Melistas L, Mantzoros CS, Kontogianni M, Antonopoulou S, Ordovas JM, Yiannakouris N: Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 2009; 161:845-852.
55. Jang Y, Chae JS, Koh SJ, Hyun YJ, Kim JY, Jeong YJ, Park S, Ahn CM, Lee JH: The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008; 391:85-90.
56. Wang J, Shang LX, Dong X, Wang X, Wu N, Wang SH, Zhang F, Xu LM, Xiao Y: Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight. Aust N Z J Obstet Gynaecol 2010; 50:432-438.
57. McDonald EA, Wolfe MW: Adiponectin attenuation of endocrine function within human term trophoblast cells. Endocrinology 2009; 150:4358-4365.
58. Lappas M, Yee K, Permezel M, Rice GE: Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005; 186:457-465.